(E) Schematic of anti-PD-L1 (Avelumab) and anti-muDR5 (MD5-1) IgG1 antibodies. Highlighted blue area depicts avelumab's antigen binding variable domain and dark red area indicates MD5-1's antigen binding variable domain. 